|
|
|||||||||
Brief Communication |
1 Molecular Imaging and Translational Research, University of Tennessee, Knoxville, Tennessee; and 2 Applied Mathematics, University of Western Ontario, London, Ontario
Correspondence: For correspondence or reprints contact: Lindi Wahl, Applied Mathematics, Middlesex College, University of Western Ontario, London, ON N6A 5B7. E-mail: lwahl{at}uwo.ca
18F-FDG PET is increasingly being used to monitor the early response of malignant tumors to chemotherapy. Understanding the reproducibility of standardized uptake values (SUVs) is an important prerequisite in estimating what constitutes a significant change. Methods: Twenty-six patients were studied on 2 separate occasions (mean interval ± SD, 3 ± 2 d; range, 1–5 d). A static PET/CT scan was performed 94 ± 9 min after the intravenous injection of 383 ± 15 MBq of 18F-FDG. Mean and maximum SUVs (SUVmean and SUVmax, respectively) were determined for regions of interest drawn around the tumor on the first study and for the same regions of interest transferred to the second study. Results: SUVmean in tumors ranged from 1.49 to 17.48 and SUVmax ranged from 2.99 to 24.09. The correlation between SUVmean determined on the 2 separate visits was 0.99; the mean difference between the 2 measurements was 0.01 ± 0.27 SUV. The 95% confidence limits for the measurements were ±0.53. For SUVmax, the mean difference was –0.05 ± 1.14 SUV. Conclusion: Our study demonstrates that repeated measurements of SUVmean performed a few days apart are highly reproducible. A decrease of 0.5 in the SUV is statistically significant.
Key Words: 18F-FDG cancer SUV reproducibility
COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.
Related articles in JNM:
This article has been cited by other articles:
![]() |
H. A. Jacene, S. Leboulleux, S. Baba, D. Chatzifotiadis, B. Goudarzi, O. Teytelbaum, K. M. Horton, I. Kamel, K. J. Macura, H.-L. Tsai, et al. Assessment of Interobserver Reproducibility in Quantitative 18F-FDG PET and CT Measurements of Tumor Response to Therapy J. Nucl. Med., November 1, 2009; 50(11): 1760 - 1769. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Velasquez, R. Boellaard, G. Kollia, W. Hayes, O. S. Hoekstra, A. A. Lammertsma, and S. M. Galbraith Repeatability of 18F-FDG PET in a Multicenter Phase I Study of Patients with Advanced Gastrointestinal Malignancies J. Nucl. Med., October 1, 2009; 50(10): 1646 - 1654. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Wahl, H. Jacene, Y. Kasamon, and M. A. Lodge From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors J. Nucl. Med., May 1, 2009; 50(Suppl_1): 122S - 150S. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Hicks Role of 18F-FDG PET in Assessment of Response in Non-Small Cell Lung Cancer J. Nucl. Med., May 1, 2009; 50(Suppl_1): 31S - 42S. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |